Bipolar depression with inadequate response from lithium or valproate
Synexus is currently conducting a clinical research study examining the safety and effectiveness of an investigational medication in individuals with Bipolar Depression. You may qualify for this study if you: Are 18 to 65 years of age, suffer from bipolar depression, have had a previous manic, mixed, or hypomanic episode, have had a 28 day treatment with lithium or valproate without providing adequate control to depressive symptoms. Qualified participants will receive all study-related care and study medication at no cost and may be compensated for study-related time and travel.
Male & Female
Why take part?
Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.
Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.
Who is Synexus?
Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.
We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.
All Synexus studies are approved by an independent ethics committee.